Compare BioNano Genomics Inc (BNGO) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs PayPal Holdings, Inc. — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while PayPal Holdings, Inc. trades at $59.09 (market cap $50.47B). The key difference: PayPal Holdings, Inc. is far larger — about 3694.7× BioNano Genomics Inc's market cap, and PayPal Holdings, Inc. pays a 0.95% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | PYPL | |
|---|---|---|
Market Cap | $13.66M | $50.47B |
Sector | Health | Financials |
52-Week High | $4.92 | $76.13 |
52-Week Low | $1.06 | $39.08 |
Enterprise Value | $16.26M | $52.62B |
Dividend Yield | — | 0.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
PayPal (PYPL) trades at $58.73, down 0.58% today, with a bullish technical signal and strong fundamentals including a P/E of 11.15 and net income margin of 14.36%. Recent Q2 2026 earnings beat expectations with EPS of $1.38, and news highlights acquisition interest from Stripe and Advent International, though the board rejected a $53 billion offer as too low, signaling confidence in the turnaround under new leadership.
The outlook is positive with raised 2026 guidance and robust free cash flow growth, but risks include competitive pressures and economic sensitivity. Analysts are mixed with a $58.75 consensus target, slightly above the current price, suggesting moderate upside potential amid ongoing execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
